-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Initiates Coverage On Zenas BioPharma with Outperform Rating

Benzinga·03/20/2025 11:55:41
Listen to the news
Wedbush analyst Martin Fan initiates coverage on Zenas BioPharma (NASDAQ:ZBIO) with a Outperform rating.